‘Real-life’ reduction in cholesterol with statins, 1993 to 2002
Open Access
- 30 January 2008
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 65 (4) , 587-592
- https://doi.org/10.1111/j.1365-2125.2007.03066.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Effectiveness of two statin prescribing strategies with respect to adherence and cardiovascular outcomes: observational studyPharmacoepidemiology and Drug Safety, 2006
- Levels of dyslipidaemia and improvement in its management in England: results from the Health Survey for England 2003Clinical Endocrinology, 2006
- Impact on cardiovascular events of increasing high density lipoprotein cholesterol with and without lipid lowering drugsHeart, 2005
- Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statinsThe Lancet, 2005
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- The Tayside Medicines Monitoring Unit (MEMO)Published by Wiley ,2000
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)The Lancet, 1994